18 May 2013
Keywords: Algeta, Alpharadin, Bayer, USA office, Facilities
Article | 19 September 2012
In anticipation of the launch of Alpharadin (radium-223 chloride), for the treatment of cancer patients with bone metastases, Norwegian cancer ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 September 2012
18 September 2012
17 May 2013
© 2013 thepharmaletter.com